Antimicrobial Resistance (AMR)
Coordinating civil society advocacy on antimicrobial stewardship, diagnostics access, and One Health policy to counter drug resistance globally.
The AMR Committee is IDA's platform for coordinated civil society action on antimicrobial resistance. We unite member organisations to develop joint policy positions, engage WHO and G7 AMR processes, and translate field expertise into actionable recommendations on stewardship, diagnostics, and cross-sector governance. Our work bridges human health, animal health, and environmental sectors under a unified One Health advocacy approach.
🦠
Specialized
Committes
79
Member Organisations
16
Countries Represented
Stronger
Together for Impact
Evidence
to Policy in Action
+
+
Our Objectives
Stewardship & Responsible Use
Promote evidence-based prescribing and dispensing practices across human, animal, and environmental sectors to slow AMR emergence.
Policy Translation
Translate AMR research and field evidence into actionable recommendations for WHO, G7, and national AMR action plans.
Equitable Diagnostics Access
Expand access to rapid, affordable AMR diagnostics in low- and middle-income countries where resistance burden is highest.
Civil Society Coordination
Coordinate joint civil society positions for global AMR governance forums and the UN General Assembly High Level Meeting on AMR.
One Health Surveillance
Support integrated surveillance connecting human, animal, and environmental AMR data for comprehensive resistance monitoring.
Bridging Science & Advocacy
Connect scientific expertise with advocacy practice — as demonstrated at the March 2025 Copenhagen hybrid event.
Committee Leadership
Committee Manager
